Aarey Drugs & Ph News
AllNewsAnnouncementRecos
BSE LIVE
Change:
Volume:
Open:
Prv. Close:
Bid:
()
Offer:
()
NSE LIVE
Change:
Volume:
Open:
Prv. Close:
Bid:
()
Offer:
()
Aarey Drugs & Pharmaceuticals Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
| AnnouncementCompliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Aarey Drugs & Pharmaceuticals Announcement under Regulation 30 (LODR)-Newspaper Publication
| AnnouncementNEwspaper Publication
Aarey Drugs & Pharmaceuticals Compliances-Reg.24(A)-Annual Secretarial Compliance
| AnnouncementReg 24A - Annual Secretarial Compliance Report
Aarey Drugs & Pharmaceuticals Board Meeting Intimation for Financial Audited Result Of March 2024
| AnnouncementAAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Financial Audited Result of March 2024
Aarey Drugs & Pharmaceuticals Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
| AnnouncementFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
Sr. No. | Particulars | Details |
1 | Name of Company | AAREY DRUGS & PHARMACEUTICALS LTD. |
2 | CIN NO. | L99999MH1990PLC056538 |
3 | Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) | 36.66 |
4 | Highest Credit Rating during the previous FY | BBB |
4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | ACUITE RATINGS & RESEARCH LIMITED |
5 | Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework | BSE |
Designation: Company Secretary
EmailId: [email protected]
Date: 30/04/2024
Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Aarey Drugs & Pharmaceuticals Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
| AnnouncementFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
Sr. No. | Particulars | Details |
1 | Name of Company | AAREY DRUGS & PHARMACEUTICALS LTD. |
2 | CIN NO. | L99999MH1990PLC056538 |
3 | Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) | 36.66 |
4 | Highest Credit Rating during the previous FY | BBB |
4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | ACUITE RATINGS & RESEARCH LIMITED |
5 | Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework | BSE |
Designation: Company Secretary
EmailId: [email protected]
Date: 30/04/2024
Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Aarey Drugs & Pharmaceuticals Reg 7(3)- Compliance Certificate
| AnnouncementReg 7(3) - Compliance Certificate
Aarey Drugs & Pharmaceuticals Certificate Under Regulation 40 (9) Of SEBI LODR, Regulations 2015
| AnnouncementCertificate under Regulation 40(9) of SEBI LODR, Regulations 2015
Aarey Drugs & Pharmaceuticals Reg 32- Statement Of Deviation
| AnnouncementReg 32 - Statement of Deviation
Aarey Drugs & Pharmaceuticals Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
| AnnouncementCompliance Certificate under Regulation 74(5)
Aarey Drugs & Pharmaceuticals Announcement under Regulation 30 (LODR)-Allotment
| AnnouncementAllotment of Securities
Aarey Drugs & Pharmaceuticals Board Meeting Outcome for Outcome Of Board Meeting
| AnnouncementOutcome of Board Meeting
Aarey Drugs & Pharmaceuticals Board Meeting Intimation for Allotment Of Equity Shares And Warrants
| AnnouncementAAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2024 ,inter alia, to consider and approve Allotment of Equity Shares and Warrants
Aarey Drugs & Pharmaceuticals Unaudited Financial Result For December 2023
| AnnouncementUnaudited financial Result for december 2023
Aarey Drugs & Pharmaceuticals Unaudited Financial Result For December 2023
| AnnouncementUnaudited Financial Result for December 2023
Aarey Drugs & Pharmaceuticals Board Meeting Intimation for Unaudited Financial Result
| AnnouncementAAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve Unaudited Financial result
Aarey Drugs & Pharmaceuticals Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
| AnnouncementCertificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Aarey Drugs & Pharmaceuticals Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
| AnnouncementScrutinizers Report
Aarey Drugs & Pharmaceuticals Shareholder Meeting / Postal Ballot-Outcome of EGM
| AnnouncementOutcome
Aarey Drugs & Pharmaceuticals Announcement under Regulation 30 (LODR)-Newspaper Publication
| AnnouncementNewspaper Publication
Aarey Drugs & Pharmaceuticals Notice Of EGM ,EGM Scheduled To Be Held As On 29Th December 2023
| AnnouncementNotice of EGM
Aarey Drugs & Pharmaceuticals Announcement under Regulation 30 (LODR)-Newspaper Publication
| AnnouncementNewspaper Publication
Aarey Drugs & Pharmaceuticals Unaudited Financial Result For September 2023
| AnnouncementUnaudited financial Result for September 2023
Aarey Drugs & Pharmaceuticals Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
| AnnouncementAmendments under Regulation 30
Aarey Drugs & Pharmaceuticals Shareholder Meeting / Postal Ballot-Scrutinizers Report
| AnnouncementShareholder Meeting - Scrutinizers Report
Aarey Drugs & Pharmaceuticals Shareholder Meeting / Postal Ballot-Outcome of AGM
| AnnouncementShareholders meeting proceedings
Aarey Drugs & Pharmaceuticals Announcement under Regulation 30 (LODR)-Newspaper Publication
| AnnouncementNewspaper Publication for June Result
Aarey Drugs & Pharmaceuticals Announcement under Regulation 30 (LODR)-Newspaper Publication
| AnnouncementNewspaper Publication
Aarey Drugs & Pharmaceuticals Unaudited Financial Result For June 2023
| AnnouncementUnaudited Financial Result for June 2023
In the Nifty 50 index, 34 stocks were trading in the green, while 16 stocks were trading in the red.